Search Results Search Sort by RelevanceMost Recent Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606. Case and Commentary Mar 2008 Duty to Warn and Dissociative Identity Disorder Michael A. Norko, MD How to treat a patient with a dissociative identity disorder and how to manage a threat made by one of the patient's personalities. Virtual Mentor. 2008;10(3):144-149. doi: 10.1001/virtualmentor.2008.10.3.ccas2-0803.
Case and Commentary Jun 2016 Prescribing “Off-Label”: What Should a Physician Disclose? Katrina Furey, MD and Kirsten Wilkins, MD Off-label prescribing of drugs is appropriate when their use is in the patient’s best interest on the basis of credible, published scientific data. AMA J Ethics. 2016;18(6):587-593. doi: 10.1001/journalofethics.2016.18.6.ecas3-1606.
Case and Commentary Mar 2008 Duty to Warn and Dissociative Identity Disorder Michael A. Norko, MD How to treat a patient with a dissociative identity disorder and how to manage a threat made by one of the patient's personalities. Virtual Mentor. 2008;10(3):144-149. doi: 10.1001/virtualmentor.2008.10.3.ccas2-0803.